NRSN
NeuroSense Therapeutics Ltd.Company with tickers: NRSN, NRSNW
CIK
1875091
CUSIP
M74240108
Shares Outstanding
35,349,813
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-26 | Russek-Blum Niva | Chief Technology Officer | Award | 200,000 |
| 2026-03-26 | Eisenberg Or | CFO and Secretary | Award | 200,000 |
| 2026-03-26 | Binder Hagit | General Manager | Award | 200,000 |
| 2026-03-18 | Ben-Noon Alon | Chief Executive Officer, 10% Owner | Other | 3,175,266 |
| 2026-03-18 | Ben-Noon Alon | Chief Executive Officer, 10% Owner | Other | 0 |
| 2026-03-18 | Pellizzari Christine A | Director | Other | 0 |
| 2026-03-18 | Pellizzari Christine A | Director | Other | 48,000 |
| 2026-03-18 | Claiborne Cary J | Director, Chief Executive Officer | Other | 48,000 |
| 2026-03-18 | Claiborne Cary J | Director, Chief Executive Officer | Other | 0 |
| 2026-03-18 | Golan Roy | Director | Other | 24,000 |
| 2026-03-18 | Eisenberg Or | CFO and Secretary | Other | 341,508 |
| 2026-03-18 | Eisenberg Or | CFO and Secretary | Other | 0 |
| 2026-03-18 | Eisenberg Or | CFO and Secretary | Other | 0 |
| 2026-03-18 | Tracik Ferenc | Chief Medical Officer | Other | 0 |
| 2026-03-18 | Tracik Ferenc | Chief Medical Officer | Other | 189,618 |
| 2026-03-18 | Tracik Ferenc | Chief Medical Officer | Other | 0 |
| 2026-03-18 | Binder Hagit | General Manager | Other | 10,000 |
| 2026-03-18 | Binder Hagit | General Manager | Other | 12,836 |
| 2026-03-18 | Binder Hagit | General Manager | Other | 0 |
| 2026-03-18 | Mandil-Levin Revital | Director | Other | 52,526 |
| 2026-03-18 | Mandil-Levin Revital | Director | Other | 0 |
| 2026-03-18 | Russek-Blum Niva | Chief Technology Officer | Other | 10,000 |
| 2026-03-18 | Russek-Blum Niva | Chief Technology Officer | Other | 39,881 |
| 2026-03-18 | Russek-Blum Niva | Chief Technology Officer | Other | 0 |
| 2026-03-18 | Leuchtenberger Mark | Director | Other | 0 |
| 2026-03-18 | Leuchtenberger Mark | Director | Other | 128,000 |